SCHEMBL30992583

SCHEMBL30992583

CSc1nc2c(-c3ccc(Cl)cc3)c(C#N)nn2c(=O)[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.50
▸ KMT2A Q03164 4/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ HTT P42858 2/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ RXFP1 Q9HBX9 2/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ XDH P47989 1/20 0.38
▸ KDM5A P29375 1/20 0.38
▸ PTGS1 P23219 1/20 0.37
▸ PTGS2 P35354 1/20 0.37
▸ PPARG P37231 1/20 0.36
▸ NCOR2 Q9Y618 1/20 0.36
▸ HPGD P15428 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27329679 0.84 KDM1A (0.40) LMNAKMT2AMEN1HTTXDH
SCHEMBL30992492 0.82 XDH (0.40) LMNAKMT2AKDM4EMEN1HTT
SCHEMBL30992594 0.82 XDH (0.36) LMNAKMT2AKDM4EMEN1HTT
SCHEMBL30992588 0.82 PTGS2 (0.41) LMNAKMT2AKDM4EMEN1HTT
SCHEMBL30992431 0.81 HAVCR2 (0.41) LMNAKMT2AKDM4EMEN1HTT
SCHEMBL30992444 0.76 XDH (0.35) KMT2AKDM4EMEN1HTTALDH1A1
SCHEMBL27329693 0.71 ALDH1A1 (0.37) LMNAKMT2AKDM4EMEN1HSD17B10
SCHEMBL27329413 0.68 HAVCR2 (0.37) KMT2AKDM4EMEN1ALDH1A1XDH
SCHEMBL27329419 0.67 HAVCR2 (0.38) KDM4EALDH1A1XDHHPGDHAVCR2
SCHEMBL31404525 0.66 KDM5A (0.42) LMNAKMT2AKDM4EMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4633734-A1 COMPOUNDS, COMPOSITIONS, AND MEZHODS OF TREATING DISORDERS ASSOCIATED WITH PROTEIN MISFOLDING Wavebreak Therapeutics, LLC (US) 2025-10-22 — — EP disclosed
WO-2024129881-A1 COMPOUNDS, COMPOSITIONS, AND MEZHODS OF TREATING DISORDERS ASSOCIATED WITH PROTEIN MISFOLDING WAVEBREAK THERAPEUTICS LIMITED (US) 2024-06-20 — — WO disclosed
Send feedback